Non-viral nanocarriers for siRNA delivery in breast cancer
Authors:
- 1 September 2014
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 190, 440-450
Abstract
No abstract availableKeywords
Funding Information
- NIH (CA129835, CA129421, CA151652, CA151455, CA149363)
This publication has 137 references indexed in Scilit:
- Multistage Vectored siRNA Targeting Ataxia‐Telangiectasia Mutated for Breast Cancer TherapySmall, 2013
- RNA-Based Therapeutics: Current Progress and Future ProspectsChemistry & Biology, 2012
- Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA deliveryBiomaterials, 2011
- Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Engineering RNA for Targeted siRNA Delivery and Medical ApplicationAdvanced Drug Delivery Reviews, 2010
- FoxM1 is a Novel Target of a Natural Agent in Pancreatic CancerPharmaceutical Research, 2010
- Lipid-based systemic delivery of siRNAAdvanced Drug Delivery Reviews, 2009
- Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancerSteroids, 2007
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996